Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta‐Analysis of Clinical Studies
Journal of Cosmetic Dermatology · 2026
DOI: 10.1111/jocd.70655 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Cosmetic Dermatology, 2026. Verfasst von Alaa Safia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Ziv Medical Center, Safed, Israel. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Skin Aging, Cosmetic Techniques, Neuromuscular Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Botulinum toxin type A (BoNT‐A) is widely recognized as the leading nonsurgical cosmetic treatment worldwide for diminishing dynamic wrinkles in the glabellar, forehead, and periorbital areas. While BoNT‐A is widely acknowledged for its effectiveness and popularity, there are notable inconsistencies in results, methodologies, and safety reporting across clinical studies, highlighting the necessity for the careful development of strong, evidence‐driven guidelines.
Objectives
This study aimed to compile and evaluate data from clinical research focusing on upper‐face BoNT‐A injections, specifically regarding safety outcomes, effectiveness, patient satisfaction, and response rates. This investigation concentrated on the outcomes of the clinical trials conducted.
Methods
This analysis includes prospective cohorts, randomized controlled trials, and observational studies that report on BoNT‐A cosmetic treatments specifically in the upper face area. A thorough examination of MEDLINE, EMBASE, Cochrane Library, and Web of Science studies was conducted, covering literature up to May 2025. The assessment included response rates, levels of patient satisfaction, and the extent of wrinkle reduction. The analysis employed a random‐effects model to produce combined estimates, followed by an assessment of heterogeneity utilizing τ 2 , I 2 , and Cochran's Q . Forest diagrams and Egger's test were utilized to evaluate publication bias and the effects of small studies when applicable.
Results
After the administration of BoNT‐A therapy, a notable decrease in the severity ratings of wrinkles was observed, as indicated by the synthesis of ten clinical trials examining this aspect (Cohen's d = 1.93; 95% CI: 1.60–2.25; p = 0.001). However, the data also revealed a considerable degree of variability ( I 2 = 90%). The findings indicated substantial variability in effect sizes related to patient satisfaction across four distinct trials (Cohen's d = 22.54; 95% CI: −2.07–47.15; p = 0.07), accompanied by significant heterogeneity ( I 2 = 99.9%) and potential indications of publication bias. The findings revealed significant variability ( I 2 = 100%) and wide prediction intervals, indicating substantial inconsistency and limited applicability of the response outcomes in future research. Analysis of five studies regarding response rates revealed a significant overall effect (Cohen's d = 34.30; 95% CI: 3.65–64.94; p = 0.28). The overall impact was determined to be noteworthy.
Conclusions
BoNT‐A injections contribute to a decrease in wrinkle severity and improve clinical results for rejuvenating the upper face. Research indicates notable variability and susceptibility to bias regarding patient satisfaction and response rates. The findings emphasize the necessity for subgroup analyses, enhanced reporting methodologies, and uniform outcome evaluations to identify factors contributing to variability in responses to BoNT‐A therapy. Trial Registration This study was conducted in accordance with PROSPERO guidelines
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology, Ziv Medical Center, Safed, Israel.
- Department of Dermatology, Rambam Health Care Campus, Haifa, Israel.
- Department of Dermatology, Ziv Medical Center, Safed, Israel.
ORCID-Profile: Alaa Safia
Zitieren
APA
Safia, A., Elhadi, U. A., Merchavy, S., Batheesh, R., & Bathish, N. (2026). Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta‐Analysis of Clinical Studies. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70655
Vancouver
Safia A, Elhadi UA, Merchavy S, Batheesh R, Bathish N. Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta‐Analysis of Clinical Studies. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70655
BibTeX
@article{Safia2026,
author = {Safia, Alaa and Elhadi, Uday Abd and Merchavy, Shlomo and Batheesh, Ramzy and Bathish, Naji},
title = {Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta‐Analysis of Clinical Studies},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
doi = {10.1111/jocd.70655}
}
EUVIMED